Prollenium® Medical Technologies Inc. manufactures the Revanesse® range of dermal fillers and SoftFil® micro-cannulas. ISO 13485 (Medical Devices) and ISO 22716 (Cosmetics GMP) certified, with FDA and Health Canada approvals and CE-marked products, Prollenium® has distributed over 8.2 million Revanesse® syringes and 10 million SoftFil® micro-cannulas across 70+ countries. Our two advanced Canadian manufacturing facilities span 80,000+ sq. ft. of R&D labs, testing environments, aseptic clean suites, and automated packaging lines—the first sites in North America to manufacture hyaluronic acid dermal fillers. Through continued investment in R&D and vertical manufacturing, Prollenium® delivers innovative medical devices and cosmetic solutions designed to meet the evolving needs of the aesthetic industry.